GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abera Bioscience AB (XSAT:ABERA) » Definitions » Net Income (Continuing Operations)

Abera Bioscience AB (XSAT:ABERA) Net Income (Continuing Operations) : kr-7.63 Mil (TTM As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Abera Bioscience AB Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Abera Bioscience AB's Net Income (Continuing Operations) for the three months ended in Jun. 2024 was kr-0.67 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Jun. 2024 was kr-7.63 Mil.


Abera Bioscience AB Net Income (Continuing Operations) Historical Data

The historical data trend for Abera Bioscience AB's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abera Bioscience AB Net Income (Continuing Operations) Chart

Abera Bioscience AB Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Income (Continuing Operations)
Get a 7-Day Free Trial -2.47 -3.64 -9.17 -19.38 -16.72

Abera Bioscience AB Quarterly Data
Dec18 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Net Income (Continuing Operations) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.74 -4.19 -2.42 -0.36 -0.67

Abera Bioscience AB Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-7.63 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Abera Bioscience AB  (XSAT:ABERA) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.


Abera Bioscience AB Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Abera Bioscience AB's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.


Abera Bioscience AB Business Description

Industry
Traded in Other Exchanges
N/A
Address
Svetsarvagen 15, Solna, SWE, SE-17141
Abera Bioscience AB is a platform and vaccine development company based on research in the medical, molecular, and microbiological fields. The company's mission is to develop vaccine candidates based on its novel vaccine delivery platform to late pre-clinical or early clinical phase.

Abera Bioscience AB Headlines

No Headlines